AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy.
about
Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesisTranscriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki ratsCopy-number variation associated with congenital anomalies of the kidney and urinary tract.Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
P2860
AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AKR1B10 is induced by hypergly ...... nts with diabetic nephropathy.
@en
AKR1B10 is induced by hypergly ...... nts with diabetic nephropathy.
@nl
type
label
AKR1B10 is induced by hypergly ...... nts with diabetic nephropathy.
@en
AKR1B10 is induced by hypergly ...... nts with diabetic nephropathy.
@nl
prefLabel
AKR1B10 is induced by hypergly ...... nts with diabetic nephropathy.
@en
AKR1B10 is induced by hypergly ...... nts with diabetic nephropathy.
@nl
P2093
P2860
P1476
AKR1B10 is induced by hypergly ...... nts with diabetic nephropathy.
@en
P2093
Andrea Hodgkinson
Andrew Demaine
Ann Millward
Bingmei Yang
Nicholas Shaw
P2860
P2888
P304
P356
10.1007/S12192-013-0455-6
P577
2013-08-23T00:00:00Z